Table 1.
Characteristics Of Patients Included In The Study
| Variables | FEV1 < 50 (n=38) | FEV1 ≥ 50 (n=52) | P-value | |
|---|---|---|---|---|
| Age (years) | 60.03 (7.49) | 58.846 (7.37) | 0.458a | |
| Time elapsed from diagnosis (years) | 6.26 (4.17) | 4.96 (3.51) | 0.113a | |
| Calorie intake | 1559.46 ± 344.62 | 1534.27 ± 292.73 | 0.709a | |
| Satiety score | 53.66 ± 14.93 | 54.83 ± 13.52 | 0.699a | |
| FVC (%predicted) | 53.13 ± 13.65 | 74.29 ± 15.07 | <0.001a | |
| FEV1 (%predicted) | 36.68 ± 10.05 | 60.59 ± 7.37 | <0.001a | |
| FEV1/FVC ratio | 46.77 ± 7.49 | 57.67 ± 6.17 | <0.001a | |
| Physical activity | Low | 25 (65.79) | 33 (63.46) | 0.82b |
| Moderate | 13 (34.21) | 19 (36.54) | ||
| Drug therapy | Salbutamol | 38 (100) | 44 (84.61) | 0.08b |
| Prednisolone | 33 (86.84) | 36 (72) | 0.06b | |
| Salmeterol + fluticasone | 30 (78.94) | 34 (68) | 0.14b | |
| Azithromycin | 19 (50) | 27 (51.92) | 0.48b | |
Notes: Quantitative and qualitative variables are represented as mean ± SD and frequency (%), respectively. aP-values are reported based on independent sample’s t-test. bP-values are reported based on chi-squared test.